Your browser doesn't support javascript.
loading
Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.
Kosmoliaptsis, V; Jöris, M M; Mallon, D H; Lankester, A C; von dem Borne, P A; Kuball, J; Bierings, M; Cornelissen, J J; Groenendijk-Sijnke, M E; van der Holt, B; Bradley, J A; Oudshoorn, M; van Rood, J J; Taylor, C J; Claas, F H J.
Afiliación
  • Kosmoliaptsis V; 1] Department of Surgery, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK [2] Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
  • Jöris MM; 1] Europdonor Foundation, Leiden, The Netherlands [2] Department of Immunohematology and Blood Transfusion, LUMC, Leiden, The Netherlands.
  • Mallon DH; Department of Surgery, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Lankester AC; Department of Pediatrics, LUMC, Leiden, The Netherlands.
  • von dem Borne PA; Department of Hematology, LUMC, Leiden, The Netherlands.
  • Kuball J; Department of Hematology and Immunology, UMCU, Utrecht, The Netherlands.
  • Bierings M; Wilhelmina Children's Hospital, UMCU, Utrecht, The Netherlands.
  • Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Groenendijk-Sijnke ME; HOVON Data Centre, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, The Netherlands.
  • van der Holt B; HOVON Data Centre, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, The Netherlands.
  • Bradley JA; Department of Surgery, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Oudshoorn M; 1] Europdonor Foundation, Leiden, The Netherlands [2] Department of Immunohematology and Blood Transfusion, LUMC, Leiden, The Netherlands.
  • van Rood JJ; 1] Europdonor Foundation, Leiden, The Netherlands [2] Department of Immunohematology and Blood Transfusion, LUMC, Leiden, The Netherlands.
  • Taylor CJ; Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
  • Claas FH; Department of Immunohematology and Blood Transfusion, LUMC, Leiden, The Netherlands.
Bone Marrow Transplant ; 50(4): 540-4, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25621806
ABSTRACT
We determined whether assessment of the immunogenicity of individual donor-recipient HLA mismatches based on differences in their amino-acid sequence and physiochemical properties predicts clinical outcome following haematopoietic SCT (HSCT). We examined patients transplanted with 9/10 single HLA class I-mismatched grafts (n=171) and 10/10 HLA-A-, -B-, -C-, -DRB1- and -DQB1-matched grafts (n=168). A computer algorithm was used to determine the physiochemical disparity (electrostatic mismatch score (EMS) and hydrophobic mismatch score (HMS)) of mismatched HLA class I specificities in the graft-versus-host direction. Patients transplanted with HLA-mismatched grafts with high EMS/HMS had increased incidence of ⩾grade II acute GVHD (aGVHD) compared with patients transplanted with low EMS/HMS grafts; patients transplanted with low and medium EMS/HMS grafts had similar incidence of aGVHD to patients transplanted with 10/10 HLA-matched grafts. Mortality was higher following single HLA-mismatched HSCT but was not correlated with HLA physiochemical disparity. Assessment of donor-recipient HLA incompatibility based on physiochemical HLA disparity may enable better selection of HLA-mismatched donors in HSCT.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bases de Datos Factuales / Trasplante de Células Madre Hematopoyéticas / Donante no Emparentado / Enfermedad Injerto contra Huésped / Antígenos HLA Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bases de Datos Factuales / Trasplante de Células Madre Hematopoyéticas / Donante no Emparentado / Enfermedad Injerto contra Huésped / Antígenos HLA Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2015 Tipo del documento: Article